1. Up Front

   Up Front 16 March 2022 Pages: 749 - 750

   

2. When therapeutic drugs lead to diabetes

   • Bruno Fève
   • André J. Scheen

   Review 04 March 2022 Pages: 751 - 762

   

3. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts

   • Eliza Fraszczyk
   • Annemieke M. W. Spijkerman
   • Harold Snieder

   Article Open access 15 February 2022 Pages: 763 - 776

   

4. Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation—relevance for (pre)diabetes: The Maastricht Study

   • Evelien J. Vandercappellen
   • Annemarie Koster
   • Coen D. A. Stehouwer

   Article Open access 04 February 2022 Pages: 777 - 789

   

5. Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes

   • Venexia M. Walker
   • Marijana Vujkovic
   • Scott M. Damrauer

   Article Open access 07 February 2022 Pages: 790 - 799

   

6. Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes

   • Mei-Hsin Su
   • Ying-Hsiu Shih
   • Shi-Heng Wang

   Article 23 February 2022 Pages: 800 - 810

   

7. Spatial and transcriptional heterogeneity of pancreatic beta cell neogenesis revealed by a time-resolved reporter system

   • Shugo Sasaki
   • Michelle Y. Y. Lee
   • Takeshi Miyatsuka

   Article 03 March 2022 Pages: 811 - 828

   

8. Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells

   • Rabea Dettmer
   • Isabell Niwolik
   • Ortwin Naujok

   Article Open access 05 February 2022 Pages: 829 - 843

   

9. Early DNA methylation changes in children developing beta cell autoimmunity at a young age

   • Inna Starskaia
   • Essi Laajala
   • Riitta Lahesmaa

   Article Open access 10 February 2022 Pages: 844 - 860

   

10. Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion

    • Rita S. Patarrão
    • Nádia Duarte
    • Carlos Penha-Gonçalves

    Article Open access 22 February 2022 Pages: 861 - 871

    

11. Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort

    • Paul Z. Benitez-Aguirre
    • M. Loredana Marcovecchio
    • on behalf of the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)

    Short Communication Open access 19 February 2022 Pages: 872 - 878

    

12. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice

    • Yan Qiu
    • Stanley Buffonge
    • Simon C. Satchell

    Article Open access 25 February 2022 Pages: 879 - 894

    

13. Reversibility of brain glucose kinetics in type 2 diabetes mellitus

    • Elizabeth Sanchez-Rangel
    • Felona Gunawan
    • Janice Jin Hwang

    Article Open access 05 March 2022 Pages: 895 - 905

    

14. Ertugliflozin, renoprotection and potential confounding by muscle wasting

    • Dion Groothof
    • Adrian Post
    • Stephan J. L. Bakker

    Letter 23 December 2021 Pages: 906 - 907

15. Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]

    • David Z. I. Cherney
    • Bernard Charbonnel
    • on behalf of the VERTIS CV Investigators

    Letter Open access 03 March 2022 Pages: 908 - 911

16. Correction to: A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY

    • Jarno L. T. Kettunen
    • Elina Rantala
    • Tiinamaija Tuomi

    Correction 03 March 2022 Pages: 912 - 912